Yahoo Finance Amgen Earnings, Revenue Beat in Q3
Investing.com - Amgen (NASDAQ:AMGN) reported third quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $3.66 on revenue of $5.74B. Analysts polled by Investing.com expected EPS of $3.53 on revenue of $5.64B. That compared to EPS of $3.69 on revenue of $5.9B in the same period a year earlier. The company had reported EPS of $3.97 on revenue of $5.87B in the previous quarter.
Amgen shares gained 2.42% to trade at $214.00 in after-hours trade following the report.
Amgen follows other major Healthcare sector earnings this month
On October 15, J&J reported third quarter EPS of $2.12 on revenue of $20.73B, compared to forecasts of EPS of $2.01 on revenue of $20.08B.
Merck&Co earnings beat analysts' expectations on Tuesday, with third quarter EPS of $1.51 on revenue of $12.4B. Investing.com analysts expected EPS of $1.24 on revenue of $11.65B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Related Articles
RBC’s Record Canadian Bail-In Bond Gains in Trading Debut
Beyond Meat, Shopify Fallout Is Latest Sign of Growth Reckoning
U.S. telecoms supply chain rules under review at Commerce Department: official
